Evolution Capital Management »

Effector Therapeutics shares owned by Evolution Capital Management

Quarter-by-quarter ownership of Effector Therapeutics (EFTRW) shares owned by Evolution Capital Management from 13F filings

Historical chart of Evolution Capital Management investment in Effector Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Effector Therapeutics held by Evolution Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Effector Therapeutics by Evolution Capital Management

Quarter filed Position value Share count Share price at filing
2022-12-31 $8.2k 50k 0.16
2022-09-30 $10k 50k 0.20
2022-06-30 $13k 50k 0.26

More positions owned by Evolution Capital Management

Alibaba Group Hldg Sponsored Ads (BABA)
Jd.com Spon Adr Cl A (JD)
Black Spade Acquisition Shs Cl A
Trip Com Group Ads (TCOM)
Thunder Brdg Cap Prtnrs Iv I Class A Com (THCP)
Bilibili Spons Ads Rep Z (BILI)
Elliott Opportunity Ii Corp Shs Cl A
L Catterton Asia Acquisition Class A Ord Shs
GDS HLDGS Sponsored Ads (GDS)
Baidu Spon Adr Rep A (BIDU)
Redfin Corp (RDFN)
Iclick Interactive Asia Grou Spon Ads New (ICLK)
Spdr Ser Tr S&p Bk Etf (KBE)
Netease Sponsored Ads (NTES)
Live Oak Mobility Acquisi Com Cl A

View all positions for Evolution Capital Management

Top funds holding Effector Therapeutics

Aristeia Capital
Goldman Sachs Group
Whitebox Advisors
MMCAP International Inc. SPC
Parallel Advisors
Millennium Management
III Capital Management
Tenor Capital Management
Sea Otter Advisors
Wolverine Asset Management
UBS Group
Pineridge Advisors

View all funds holding Effector Therapeutics